Reliance Life Sciences Pvt Ltd - Page Profile

Category: Pharmaceutical
- Last updated January 13, 2016
- 0 comments, 2 views, 1 like, 0 followers, 1 fans/members/followers
R-282, TTC Industrial Area of MIDC, Thane-Belapur Road, Rabale, Navi Mumbai 400 701 - Get Directions

Reliance Life Sciences Pvt Ltd updated a new cover photo.

January 13, 2016
Insert Emoticons
the trade book directory likes the page Reliance Life Sciences Pvt Ltd:

January 13, 2016

Reliance Life Sciences Pvt Ltd

The Reliance Group is Indiaâ€™s largest private sector enterprise, with annual revenues of US$ 66.8 billion. The Groupâ€™s activities span oil and gas exploration and production, petroleum refining, petrochemicals, polyester, plastics, organized retailing...
Insert Emoticons
the trade book directory created a new page:

January 13, 2016

Reliance Life Sciences Pvt Ltd

The Reliance Group is Indiaâ€™s largest private sector enterprise, with annual revenues of US$ 66.8 billion. The Groupâ€™s activities span oil and gas exploration and production, petroleum refining, petrochemicals, polyester, plastics, organized retailing...
- the trade book directory likes this.
Insert Emoticons

There are no more results to show.

Category: Pharmaceutical
Location: R-282, TTC Industrial Area of MIDC, Thane-Belapur Road, Rabale, Navi Mumbai 400 701 - Get Directions
Description: The Reliance Group is Indiaâ€™s largest private sector enterprise, with annual revenues of US$ 66.8 billion. The Groupâ€™s activities span oil and gas exploration and production, petroleum refining, petrochemicals, polyester, plastics, organized retailing and telecom. The Groupâ€™s... more

0 Comments | the trade book directory likes this.

Reliance Life Sciences Pvt Ltd's Albums • 2 Photo Albums

2 of 2 albums See All

a.	Biopharmaceuticals (Plasma Proteins, Biosimilars (Recombinant Proteins, Monoclonal Antibodies) and Novel Proteins)
b.	Pharmaceuticals (Oncology, Steroid, Hormone and Peptide - Active Pharmaceutical Ingredients and Formulations )
c.	Clinical Research Services (Pre-clinical animal studies, Bioavailability and Bioequivalence studies, Phase 1 studies, Phase 2 to 4 studies, QTc studies, Mass balance/Micro dosing studies, Clinical Data Management, Biostatistics, Clinical Trial Supplies Management, Medical Writing, Pharmacovigliance, Regulatory Services and Quality Assurance)
d.	Regenerative Medicine (Stem Cell therapies, Tissue Engineered products, Stem Cell enriched Repository Services, Assisted Reproduction and Fetal Medicine)